We observed decreased mitochondrial activity in GCT cells treated with an increasing FGF-2 dosage when compared to untreated GCT stromal cells after 48 h, indicating decreased proliferation and cell viability with FGF-2 treatment (Fig. 2c). The gene discussed is FGF2; the disease is granular cell tumor.